Atea Pharmaceuticals, Inc. financial data

Symbol
AVIR on Nasdaq
Industry
Pharmaceutical Preparations
Location
225 Franklin Street, Suite 2100, Boston, Massachusetts
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
Q1 2024 - May 14, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 2.17K % -41.6%
Debt-to-equity 6.17 % +54.2%
Return On Equity -29.2 % -72.4%
Return On Assets -27.5 % -68.8%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 84.2M shares +0.99%
Common Stock, Shares, Outstanding 84.2M shares +0.99%
Entity Public Float 284M USD -47.2%
Common Stock, Value, Issued 84K USD +1.21%
Weighted Average Number of Shares Outstanding, Basic 83.9M shares +0.7%
Weighted Average Number of Shares Outstanding, Diluted 83.9M shares +0.7%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 143M USD +75.8%
General and Administrative Expense 49.5M USD +1.53%
Operating Income (Loss) -192M USD -47.9%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -163M USD -44.3%
Income Tax Expense (Benefit) 1.05M USD +17.3%
Net Income (Loss) Attributable to Parent -164M USD -49.7%
Earnings Per Share, Basic -1.95 USD/shares -48.9%
Earnings Per Share, Diluted -1.95 USD/shares -48.9%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 161M USD -12.2%
Cash, Cash Equivalents, and Short-term Investments 542M USD -12.7%
Accounts Receivable, after Allowance for Credit Loss, Current 4.51M USD
Assets, Current 549M USD -13.2%
Property, Plant and Equipment, Net 1.19M USD -26%
Operating Lease, Right-of-Use Asset 1.68M USD -25.2%
Other Assets, Noncurrent 1.4M USD -17.4%
Assets 553M USD -13.3%
Accounts Payable, Current 21.1M USD +2920%
Employee-related Liabilities, Current 2.33M USD -2.79%
Liabilities, Current 41.3M USD +234%
Accrued Income Taxes, Noncurrent 5.9M USD +9.85%
Operating Lease, Liability, Noncurrent 1.45M USD -34.8%
Liabilities 48.7M USD +144%
Accumulated Other Comprehensive Income (Loss), Net of Tax -181K USD +41%
Retained Earnings (Accumulated Deficit) -259M USD -172%
Stockholders' Equity Attributable to Parent 504M USD -18.4%
Liabilities and Equity 553M USD -13.3%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -39.9M USD -33.6%
Net Cash Provided by (Used in) Financing Activities 150K USD -9.09%
Net Cash Provided by (Used in) Investing Activities -44K USD
Common Stock, Shares Authorized 300M shares 0%
Common Stock, Shares, Issued 84.2M shares +0.99%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 17.1M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 161M USD -12.3%
Deferred Tax Assets, Valuation Allowance 74.2M USD +80.2%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 74.2M USD +80.2%
Operating Lease, Liability 2.21M USD -24.8%
Payments to Acquire Property, Plant, and Equipment 1.94M USD +48475%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -164M USD -49.2%
Lessee, Operating Lease, Liability, to be Paid 2.31M USD -25.9%
Property, Plant and Equipment, Gross 1.98M USD 0%
Operating Lease, Liability, Current 769K USD +5.34%
Lessee, Operating Lease, Liability, to be Paid, Year Two 855K USD +2.03%
Lessee, Operating Lease, Liability, to be Paid, Year One 838K USD +2.07%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 95K USD -45.1%
Lessee, Operating Lease, Liability, to be Paid, Year Three 855K USD +2.03%
Deferred Tax Assets, Operating Loss Carryforwards 9.39M USD +67.9%
Preferred Stock, Shares Issued 0 shares
Current Income Tax Expense (Benefit) -3.83M USD -163%
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 5.76M USD +9.57%
Lessee, Operating Lease, Liability, to be Paid, Year Four 855K USD +2.03%
Additional Paid in Capital 763M USD +6.97%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Share-based Payment Arrangement, Expense 49.5M USD +3.97%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%